Valuation Astellas Pharma Inc. OTC Markets

Stocks

ALPMY

US04623U1025

Pharmaceuticals

Market Closed - OTC Markets Other stock markets 15:59:46 2026-06-15 EDT			5-day change	1st Jan Change
13.38 ^USD	-0.30%		-0.82%	+0.68%

06-04	Astellas Pharma Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:10 AM
06-03	Astellas Pharma Inc. - Special Call

Company Valuation: Astellas Pharma Inc.

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	3,161,421	3,519,738	3,381,409	2,946,773	2,589,390	3,856,187	-	-
Change	-	11.33%	-3.93%	-12.85%	-12.13%	48.92%	-	-
Enterprise Value (EV) ¹	2,829,733	3,203,752	3,004,569	2,611,086	3,232,444	4,796,910	3,753,428	3,485,523
Change	-	13.22%	-6.22%	-13.1%	23.8%	48.4%	-12.4%	-7.14%
P/E Ratio	26.2x	28.5x	34.7x	173x	51x	15.5x	11x	11.8x
PBR	2.28x	2.39x	2.24x	1.85x	1.71x	2.47x	1.98x	1.84x
PEG	-	8.61x	-1.8x	-2.1x	0x	0x	0.8x	-1.91x
Capitalization / Revenue	2.53x	2.72x	2.23x	1.84x	1.35x	2.11x	1.72x	1.86x
EV / Revenue	2.26x	2.47x	1.98x	1.63x	1.69x	2.24x	1.67x	1.68x
EV / EBITDA	13.6x	13.6x	12.6x	14.2x	13.5x	8.31x	5.79x	5.64x
EV / EBIT	20.8x	20.6x	22.6x	102x	78.8x	12.5x	8.12x	7.99x
EV / FCF	10.3x	14.1x	10.3x	-3.88x	20.5x	9.72x	10x	6.85x
FCF Yield	9.73%	7.08%	9.7%	-25.8%	4.87%	10.3%	9.96%	14.6%
Dividend per Share ²	42	50	60	70	74	78	80.5	83.08
Rate of return	2.47%	2.62%	3.19%	4.26%	5.12%	3.1%	3.74%	3.86%
EPS ²	64.93	67.08	54.24	9.51	28.35	162.8	195.2	183.2
Distribution rate	64.7%	74.5%	111%	736%	261%	47.9%	41.2%	45.4%
Net sales ¹	1,249,528	1,296,163	1,518,619	1,603,672	1,912,323	2,139,245	2,243,845	2,068,752
EBITDA ¹	208,703	235,370	238,767	183,358	240,171	577,227	648,720	617,576
EBIT ¹	136,051	155,686	133,029	25,518	41,039	382,633	462,270	436,084
Net income ¹	120,589	124,086	98,714	17,045	50,747	291,535	349,869	327,819
Net Debt ¹	-331,688	-315,986	-376,840	-335,687	643,054	284,347	-102,759	-370,664
Reference price ²	1,702.00	1,911.00	1,883.00	1,643.50	1,446.50	2,152.50	2,152.50	2,152.50
Nbr of stocks (in thousands)	1,857,474	1,841,831	1,795,756	1,792,986	1,790,107	1,791,492	-	-
Announcement Date	4/27/21	4/27/22	4/27/23	4/25/24	4/25/25	4/27/26	-	-

¹JPY in Million²JPY

Estimates

P/E Ratio, Detailed evolution

Sector Comparison:

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	33.15x	12.05x	24.81x	0.6%	1,010B
JOHNSON & JOHNSON	25.74x	5.93x	16.13x	2.22%	580B
ABBVIE INC.	27.88x	6.79x	13.86x	3.01%	402B
ROCHE HOLDING AG	17.71x	4.37x	10.73x	3.04%	330B
NOVARTIS AG	21.24x	5.49x	13.32x	2.92%	281B
ASTRAZENECA PLC	22.78x	4.74x	13.47x	1.85%	280B
NOVO NORDISK A/S	12.7x	4.75x	9.72x	3.95%	197B
AMGEN INC.	23.09x	6.16x	10.76x	2.84%	192B
GILEAD SCIENCES, INC.	-45x	5.43x	29.95x	2.58%	156B
Average	15.48x	6.19x	15.86x	2.56%	380.97B
Weighted average by Cap.	22.68x	7.47x	17.41x	2.09%